Literature DB >> 9372935

Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.

A Kelekar1, B S Chang, J E Harlan, S W Fesik, C B Thompson.   

Abstract

The Bcl-2 related protein Bad is a promoter of apoptosis and has been shown to dimerize with the anti-apoptotic proteins Bcl-2 and Bcl-XL. Overexpression of Bad in murine FL5.12 cells demonstrated that the protein not only could abrogate the protective capacity of coexpressed Bcl-XL but could accelerate the apoptotic response to a death signal when it was expressed in the absence of exogenous Bcl-XL. Using deletion analysis, we have identified the minimal domain in the murine Bad protein that can dimerize with Bcl-xL. A 26-amino-acid peptide within this domain, which showed significant homology to the alpha-helical BH3 domains of related apoptotic proteins like Bak and Bax, was found to be necessary and sufficient to bind Bcl-xL. To determine the role of dimerization in regulating the death-promoting activity of Bad and the death-inhibiting activity of Bcl-xL, mutations within the hydrophobic BH3-binding pocket in Bcl-xL that eliminated the ability of Bcl-xL to form a heterodimer with Bad were tested for the ability to promote cell survival in the presence of Bad. Several of these mutants retained the ability to impart protection against cell death regardless of the level of coexpressed Bad protein. These results suggest that BH3-containing proteins like Bad promote cell death by binding to antiapoptotic members of the Bcl-2 family and thus inhibiting their survival promoting functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372935      PMCID: PMC232560          DOI: 10.1128/MCB.17.12.7040

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  An alternatively spliced C. elegans ced-4 RNA encodes a novel cell death inhibitor.

Authors:  S Shaham; H R Horvitz
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

2.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.

Authors:  S W Muchmore; M Sattler; H Liang; R P Meadows; J E Harlan; H S Yoon; D Nettesheim; B S Chang; C B Thompson; S L Wong; S L Ng; S W Fesik
Journal:  Nature       Date:  1996-05-23       Impact factor: 49.962

3.  A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis.

Authors:  J J Hunter; T G Parslow
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

4.  Bcl-x(S) anatagonizes the protective effects of Bcl-x(L).

Authors:  A J Minn; L H Boise; C B Thompson
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  Bax-independent inhibition of apoptosis by Bcl-XL.

Authors:  E H Cheng; B Levine; L H Boise; C B Thompson; J M Hardwick
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

6.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

7.  bcl-w, a novel member of the bcl-2 family, promotes cell survival.

Authors:  L Gibson; S P Holmgreen; D C Huang; O Bernard; N G Copeland; N A Jenkins; G R Sutherland; E Baker; J M Adams; S Cory
Journal:  Oncogene       Date:  1996-08-15       Impact factor: 9.867

8.  Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.

Authors:  J M Boyd; G J Gallo; B Elangovan; A B Houghton; S Malstrom; B J Avery; R G Ebb; T Subramanian; T Chittenden; R J Lutz
Journal:  Oncogene       Date:  1995-11-02       Impact factor: 9.867

9.  The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein.

Authors:  J Han; P Sabbatini; D Perez; L Rao; D Modha; E White
Journal:  Genes Dev       Date:  1996-02-15       Impact factor: 11.361

10.  Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.

Authors:  H Zha; C Aimé-Sempé; T Sato; J C Reed
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

View more
  66 in total

1.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

3.  WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase.

Authors:  Fei Su; Michael Overholtzer; Daniel Besser; Arnold J Levine
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 4.  Regulation of apoptosis by Bcl-2 family proteins.

Authors:  Alexandrina Burlacu
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

5.  Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells.

Authors:  Yanan Zhu; Bradley J Swanson; Michael Wang; David A Hildeman; Brian C Schaefer; Xinqi Liu; Hiroyuki Suzuki; Katsuyoshi Mihara; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

6.  Effect of massive small bowel resection on the Bax/Bcl-w ratio and enterocyte apoptosis.

Authors:  L E Stern; R A Falcone; C J Kemp; L A Stuart; C R Erwin; B W Warner
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

7.  NMR determination that an extended BH3 motif of pro-apoptotic BID is specifically bound to BCL-XL.

Authors:  Hong Ji; Alex Shekhtman; Ranajeet Ghose; James M McDonnell; David Cowburn
Journal:  Magn Reson Chem       Date:  2006-07       Impact factor: 2.447

8.  Tolerogenic effect of fiber tract injury: reduced EAE severity following entorhinal cortex lesion.

Authors:  Leman Mutlu; Christine Brandt; Erik Kwidzinski; Birgit Sawitzki; Ulrike Gimsa; Jacqueline Mahlo; Orhan Aktas; Robert Nitsch; Marloes van Zwam; Jon D Laman; Ingo Bechmann
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

9.  Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2.

Authors:  Andrew E Douglas; Kevin D Corbett; James M Berger; Grant McFadden; Tracy M Handel
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

10.  BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.

Authors:  Victoria Del Gaizo Moore; Krysta D Schlis; Stephen E Sallan; Scott A Armstrong; Anthony Letai
Journal:  Blood       Date:  2007-12-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.